SCHEMBL26158577

SCHEMBL26158577

Cc1cc(NC(=O)c2cc(O)c(C(=O)O)cc2O)cc(C(=O)O)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ P2RX1 P51575 2/20 0.51
▸ TMPRSS4 Q9NRS4 2/20 0.51
▸ TPMT P51580 1/20 0.47
▸ HCAR1 Q9BXC0 1/20 0.46
▸ KMT2A Q03164 6/20 0.46
▸ MEN1 O00255 5/20 0.46
▸ POLB P06746 4/20 0.46
▸ ALDH1A1 P00352 2/20 0.46
▸ PKM P14618 2/20 0.45
▸ L3MBTL1 Q9Y468 2/20 0.45
▸ FABP1 P07148 1/20 0.45
▸ P2RY14 Q15391 1/20 0.45
▸ NPC1 O15118 3/20 0.44
▸ RAB9A P51151 3/20 0.44
▸ THRB P10828 1/20 0.44
▸ AKR1C3 P42330 1/20 0.44
▸ AKR1C2 P52895 1/20 0.44
▸ AKR1C1 Q04828 1/20 0.44
▸ KDM4E B2RXH2 2/20 0.43
▸ MAPT P10636 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23796754 0.89 PKM (0.56) P2RX1TMPRSS4KMT2AMEN1POLB
SCHEMBL23796953 0.89 KMT2A (0.51) P2RX1TMPRSS4KMT2AMEN1POLB
SCHEMBL26158581 0.85 P2RX1 (0.44) P2RX1TMPRSS4TPMTHCAR1KMT2A
SCHEMBL26158583 0.85 P2RX1 (0.44) P2RX1TMPRSS4TPMTHCAR1KMT2A
SCHEMBL26158580 0.82 HCAR1 (0.51) P2RX1TMPRSS4TPMTHCAR1KMT2A
SCHEMBL18907145 0.81 LCK (0.48) P2RX1TMPRSS4TPMTHCAR1KMT2A
SCHEMBL23817092 0.78 POLB (0.49) TPMTKMT2AMEN1POLBALDH1A1
SCHEMBL23796498 0.78 KMT2A (0.57) P2RX1KMT2AMEN1POLBALDH1A1
SCHEMBL23809718 0.77 ALDH1A1 (0.51) P2RX1TMPRSS4KMT2AMEN1POLB
SCHEMBL23796591 0.77 KMT2A (0.60) KMT2AMEN1ALDH1A1PKML3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230150951-A1 2,5- OR 2,6-DISUBSTITUTED HYDROQUINONE DERIVATIVES WITH AT LEAST ONE CARBOXY, SULFO OR AMIDO GROUP USEFUL AS MEDICAMENTS OM PHARMA SA (CH) 2023-05-18 — — US disclosed
US-20230150951-A1 2,5- OR 2,6-DISUBSTITUTED HYDROQUINONE DERIVATIVES WITH AT LEAST ONE CARBOXY, SULFO OR AMIDO GROUP USEFUL AS MEDICAMENTS OM PHARMA SA (CH) 2023-05-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230150951-A1 2,5- OR 2,6-DISUBSTITUTED HYDROQUINONE DERIVATIVES WITH AT LEAST ONE CARBOXY, SULFO OR AMIDO GROUP USEFUL AS MEDICAMENTS HRH4, NCOA4, HRH3 P2RX1 2311/4885TMPRSS4 805/4885TPMT 1781/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback